1-7 of 7
Yoshihiro Tanaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB093: Incident heart failure among young adult cancer survivors

Yoshihiro Tanaka, Phlip Greenland, Sadiya Khan, Elizabeth A. Hibler
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB093.
https://doi.org/10.1158/1538-7445.AM2021-LB093
Published: 01 July 2021
View article titled, Abstract LB093: Incident heart failure among young adult cancer survivors
Journal Articles

Abstract LB-172: A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low-dose cyclophosphamide for patients with advanced solid tumors

Yasuki Hijikata, Toshihiko Okazaki, Hiroyuki Inoue, Yoshihiro Tanaka, Kenzaburo Tani, Shinichi Kobayashi, koji Yoshida
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-172.
https://doi.org/10.1158/1538-7445.AM2014-LB-172
Published: 01 October 2014
View article titled, Abstract LB-172: A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low-dose cyclophosphamide for patients with advanced solid tumors
Journal Articles

Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy

Shingo Miyamoto, Michinari Hirata, Ayano Yamazaki, Takuya Kageyama, Hidetoshi Hasuwa, Hiroto Mizushima, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Masahiro Kai, Hideo Kanoh, Hitoo Nakano, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5720–5727.
https://doi.org/10.1158/0008-5472.CAN-04-0811
Published: 16 August 2004
View article titled, Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
Open the PDF for Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

HB-EGF is a targeting molecule for the treatment of ovarian cancer

Shingo Miyamoto, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Hitoo Nakano, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1198.
Published: 01 April 2004
View article titled, HB-EGF is a targeting molecule for the treatment of ovarian cancer
Journal Articles

The clinical significance of RCAS1 in uterine cancer patients

Kenzo Sonoda, Shingo Miyamoto, Manabu Nakashima, Hiroshi Yagi, Yoshihiro Tanaka, Takeshi Watanabe, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 440.
Published: 01 April 2004
View article titled, The clinical significance of RCAS1 in uterine cancer patients
Journal Articles

HB-EGF in ascites involved in tumor extension of ovarian cancer

Hiroshi Yagi, Shingo Miyamoto, Yoshihiro Tanaka, Kenzo Sonoda, Hiroaki Kobayashi, Eisuke Mekada, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1026.
Published: 01 April 2004
View article titled, HB-EGF in ascites involved in tumor extension of ovarian cancer
Journal Articles

The clinical significance of HB-EGF and ADAM12 expression in human ovarian cancer

Yoshihiro Tanaka, Shingo Miyamoto, Hiroshi Yagi, Kenzo Sonoda, Eiji Oki, Eisuke Mekada, Hitoo Nakano
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1029–1030.
Published: 01 April 2004
View article titled, The clinical significance of HB-EGF and ADAM12 expression in human ovarian cancer